-
31.发明申请POLYPEPTIDE, ANTI-VEGF ANTIBODY, AND ANTI-C-MET/ANTI-VEGF BISPECIFIC ANTIBODIES COMPRISING THE SAME 审中-公开多肽，抗VEGF抗体和包含该抗体的抗-C-MET /抗-VEGF-BISPECIFIC抗体公开(公告)号：US20160090427A1
公开(公告)日：2016-03-31
申请号：US14869636
申请日：2015-09-29
Applicant: Samsung Electronics Co., Ltd.
Inventor： Seung Hyun Lee , Soo Yeon Jung , Bo Gyou Kim , Seung Ja Oh , Ji Min Lee
CPC classification number: C07K16/22 , A61K39/3955 , A61K39/39558 , C07K16/2863 , C07K2317/24 , C07K2317/31 , C07K2317/622 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2319/74
Abstract: A polypeptide, an anti-VEGF antibody and an anti-c-Met/anti-VEGF bispecific antibody, which includes the polypeptide, a pharmaceutical composition including the antibody, and a method of treating cancer using the antibody.
Abstract translation: 包括该多肽的多肽，抗VEGF抗体和抗c-Met /抗VEGF双特异性抗体，包含该抗体的药物组合物和使用该抗体治疗癌症的方法。
-
公开(公告)号：US20140154251A1
公开(公告)日：2014-06-05
申请号：US14081917
申请日：2013-11-15
Applicant: Samsung Electronics Co., Ltd.
Inventor： Seung Hyun LEE , Geun Woong Kim , Kyung Ah Kim , Hye Won Park , Ho Yeong Song , Young Mi Oh , Saet Byoul Lee , Ji Min Lee , Kwang Ho Cheong , Yun Ju Jeong , Mi Young Cho , Jae Hyun Choi , Yun Jeong Song , Yoon Aa Choi
IPC: C07K16/28
CPC classification number: C07K16/2863 , A61K2039/505 , C07K2317/24 , C07K2317/52 , C07K2317/53 , C07K2317/565 , C07K2317/622 , C07K2317/73 , C07K2317/92
Abstract: An anti-c-Met antibody or antibody fragment and pharmaceutical composition comprising same, as well as a method for preventing and treating cancer by administering the antibody to a subject are provided.
Abstract translation: 提供了抗c-Met抗体或抗体片段及包含其的药物组合物，以及通过向受试者施用抗体来预防和治疗癌症的方法。
-
公开(公告)号：US11664027B2
公开(公告)日：2023-05-30
申请号：US17459327
申请日：2021-08-27
Applicant: Samsung Electronics Co., Ltd.
Inventor： Chakladar Subhojit , Sang Hoon Lee , Ji Min Lee
IPC: G10L15/22 , G10L15/065 , G10L15/06 , G10L15/30 , G10L15/183
CPC classification number: G10L15/22 , G10L15/06 , G10L15/065 , G10L15/183 , G10L15/30 , G10L2015/223
Abstract: Disclosed is a portable communication device, including a display, at least one microphone, a memory, and a processor operably connected to the display, the at least one microphone and the memory, wherein the processor is configured to display guide information, via the display, in response to a user input, the guide information including a first display object related to guide a user voice input for generation of a new voice command and a second display object related to at least one application executed by the new voice command via the portable communication device, receive audio data corresponding to the first display object from a user through the at least one microphone, generate the new voice command corresponding to the audio data, and store, in the memory, the new voice command corresponding to the received audio data and mapping information indicating that the new voice command and the at least one application are mapped.
-
公开(公告)号：US09934781B2
公开(公告)日：2018-04-03
申请号：US14755441
申请日：2015-06-30
Applicant: Samsung Electronics Co., Ltd.
Inventor： Chakladar Subhojit , Sang Hoon Lee , Ji Min Lee
IPC: G10L15/22 , G10L15/06 , G10L15/065 , G10L15/183 , G10L15/30
CPC classification number: G10L15/22 , G10L15/06 , G10L15/065 , G10L15/183 , G10L15/30 , G10L2015/223
Abstract: An electronic device, a method, and a chip set are provided. The electronic device includes a memory configured to store at least one of audio feature data of audio data and speech recognition data obtained by speech recognition of audio data; and a control module connected to the memory, wherein the control module is configured to update a voice command that is set to execute a function through voice, the function being selected based on at least one of the audio feature data, the speech recognition data, and function execution data executed in relation to the audio data.
-
Patent Agency Ranking
35.发明授权Method of combination therapy using an EGFR antagonist and anti-c-Met antibody 有权使用EGFR拮抗剂和抗c-Met抗体的联合治疗方法公开(公告)号：US09572878B2
公开(公告)日：2017-02-21
申请号：US14227759
申请日：2014-03-27
Inventor： Saet Byoul Lee , Jae Hyun Choi , Kyung Ah Kim , Ji Min Lee , Yun Ju Jeong , Keunchil Park , Youngwook Kim , Yumi Lee
IPC: A61K39/395 , A61K31/517 , A61K31/5377
CPC classification number: A61K39/3955 , A61K31/517 , A61K31/5377 , A61K31/00 , A61K2300/00
Abstract: A method of combination therapy for prevention and/or treatment of c-Met- and/or EGFR-induced diseases including co-administering a pharmaceutically effective amount of an EGFR antagonist and a pharmaceutically effective amount of an anti-c-Met antibody to a subject in need thereof is provided.
Abstract translation: 用于预防和/或治疗c-Met-和/或EGFR诱导的疾病的组合疗法的方法，包括将药学有效量的EGFR拮抗剂和药学上有效量的抗c-Met抗体共同施用于 提供了有需要的受试者。
-
36.发明授权公开(公告)号：US09457081B2
公开(公告)日：2016-10-04
申请号：US14480174
申请日：2014-09-08
Applicant: Samsung Electronics Co., Ltd.
Inventor： Ji Min Lee , Kyung Ah Kim
IPC: A01N61/00 , A61K39/395 , A61K31/519 , A61K31/506 , A61K31/454 , C12N15/113 , C07K16/28 , A61K39/00
CPC classification number: A61K39/39558 , A61K31/454 , A61K31/4545 , A61K31/506 , A61K31/519 , A61K45/06 , A61K2039/505 , C07K16/2863 , C07K2317/24 , C07K2317/622 , C07K2317/73 , C07K2317/74 , C12N15/113 , C12N2310/14 , C12N2320/31 , A61K2300/00
Abstract: A method of preventing and/or treating a cancer including co-administering a c-Met inhibitor and a beta-catenin inhibitor to a subject in need thereof, a pharmaceutical composition comprising a c-Met inhibitor and a beta-catenin inhibitor, and a kit comprising a pharmaceutical composition comprising a c-Met inhibitor, and a pharmaceutical composition comprising a beta-catenin inhibitor packaged together.
Abstract translation: 一种预防和/或治疗癌症的方法，包括将c-Met抑制剂和β-连环蛋白抑制剂共同施用于有需要的受试者，包含c-Met抑制剂和β-连环蛋白抑制剂的药物组合物和 包含包含c-Met抑制剂的药物组合物的试剂盒和包含在一起包装的β-连环蛋白抑制剂的药物组合物。
-
公开(公告)号：US09457043B2
公开(公告)日：2016-10-04
申请号：US14481509
申请日：2014-09-09
Applicant: Samsung Electronics Co., Ltd.
Inventor： Ji Min Lee , Kyung Ah Kim
IPC: A61K39/395 , A61K31/7088 , C07K16/28 , A61K39/00
CPC classification number: A61K31/7088 , A61K31/713 , A61K39/39558 , A61K45/06 , A61K2039/505 , C07K16/2863 , C07K2317/24 , A61K2300/00
Abstract: A method of preventing and/or treating a cancer including co-administering a c-Met inhibitor and a c-Myc Inhibitor to a subject in need thereof, a pharmaceutical composition comprising a c-Met inhibitor and a c-Myc inhibitor, and a kit comprising a pharmaceutically effective amount of a c-Met inhibitor as an active ingredient, and a second pharmaceutical composition comprising a pharmaceutically effective amount of a c-Myc inhibitor as an active ingredient, packaged together.
Abstract translation: 一种预防和/或治疗癌症的方法，包括向有需要的受试者共同施用c-Met抑制剂和c-Myc抑制剂，包含c-Met抑制剂和c-Myc抑制剂的药物组合物和 试剂盒包含药学上有效量的c-Met抑制剂作为活性成分，以及包含药学有效量的作为活性成分的c-Myc抑制剂的第二药物组合物，包装在一起。
-
38.发明授权Use of LRIG1 as a biomarker for identifying a subject for application of anti-c-Met antibodies 有权使用LRIG1作为鉴定受试者应用抗c-Met抗体的生物标志物公开(公告)号：US09213032B2
公开(公告)日：2015-12-15
申请号：US13949041
申请日：2013-07-23
Applicant: SAMSUNG ELECTRONICS CO., LTD.
Inventor： Ji Min Lee , Kyung Ah Kim , Bo Gyou Kim
CPC classification number: G01N33/57492 , A61K2039/505 , C07K16/2863 , C07K16/30 , C07K2317/24 , C07K2317/622 , C07K2317/73 , C07K2317/76 , C12Q1/6886 , C12Q2600/106 , C12Q2600/156 , G01N33/57496 , G01N2800/52
Abstract: A method of identifying a cell sample or subject suitable for treatment with an anti-c-Met antibody or antigen-binding fragment thereof that specifically binds to an epitope within a SEMA domain of a c-Met protein by determining the presence of LRIG1 in a cell sample from the subject, as well as related methods and compositions.
Abstract translation: 一种鉴定适合用抗c-Met抗体或其抗原结合片段治疗的细胞样品或受试者的方法，所述抗c-Met抗体或其抗原结合片段特异性结合c-Met蛋白质的SEMA结构域中的表位，通过确定c-Met蛋白中存在LRIG1 来自受试者的细胞样品，以及相关方法和组合物。
-
39.发明申请公开(公告)号：US20150071930A1
公开(公告)日：2015-03-12
申请号：US14480174
申请日：2014-09-08
Applicant: Samsung Electronics Co., Ltd.
Inventor： Ji Min Lee , Kyung Ah Kim
IPC: C07K16/32 , A61K31/519 , A61K39/395 , A61K31/454 , C12N15/113 , C07K16/18 , A61K31/506
CPC classification number: A61K39/39558 , A61K31/454 , A61K31/4545 , A61K31/506 , A61K31/519 , A61K45/06 , A61K2039/505 , C07K16/2863 , C07K2317/24 , C07K2317/622 , C07K2317/73 , C07K2317/74 , C12N15/113 , C12N2310/14 , C12N2320/31 , A61K2300/00
Abstract: A method of preventing and/or treating a cancer including co-administering a c-Met inhibitor and a beta-catenin inhibitor to a subject in need thereof, a pharmaceutical composition comprising a c-Met inhibitor and a beta-catenin inhibitor, and a kit comprising a pharmaceutical composition comprising a c-Met inhibitor, and a pharmaceutical composition comprising a beta-catenin inhibitor packaged together.
Abstract translation: 一种预防和/或治疗癌症的方法，包括将c-Met抑制剂和β-连环蛋白抑制剂共同施用于有需要的受试者，包含c-Met抑制剂和β-连环蛋白抑制剂的药物组合物和 包含包含c-Met抑制剂的药物组合物的试剂盒和包含在一起包装的β-连环蛋白抑制剂的药物组合物。
-
-
-
-
-
-
-
-
Search Results
39
records
(took 0.027 seconds)
